SUPNSupernus Pharmaceuticals, Inc.

$44.93

Is it safe?

Can SUPN take a bad year?

The deepest fall in SUPN's price history on file is −76%; it is −21% below its high today.

5.09

Altman Z-score · distress below 1.8 · safe above 3 · safe zone, the balance sheet is not what threatens this one

Annualised volatility
37%

Annualised volatility · roughly twice as jumpy as the market

Worst drawdown on file
−76%

Worst drawdown on file · −21% today

Details
Cash and short-term investments
$185M
EBITDA, trailing twelve months
−$8.2M
Operating profit, trailing twelve months
−$60M
Annualised volatilitytwo years of daily moves
37%
Worst drawdown on file
−76%
Below its 52-week high
−21%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.